減重和肥胖管理市場按治療類型、給藥途徑、年齡層、最終用戶和地區分類

減重和肥胖管理市場規模預計在 2025 年達到 1,651 億美元，預計到 2032 年將達到 2,950.9 億美元，2025 年至 2032 年的複合年成長率為 8.7%。

全球減重和肥胖管理市場是一個快速擴張的醫療保健領域，其驅動力源於不斷上升的肥胖率、日益增強的健康意識以及全球對肥胖相關併發症日益成長的認知。該市場涵蓋了全面的產品和服務，包括營養補充劑、代餐、健身器材、體重管理設備、藥物干預以及促進減肥和保持健康體重的外科手術。

糖尿病、心血管疾病和METABOLIC INC.症候群等文明病的日益流行，極大地推動了市場的成長軌跡，從而對有效的體重管理解決方案產生了迫切的需求。其他優點包括技術進步，例如非侵入性治療方案、數位健康平台以及迎合不同消費者偏好和醫療需求的個人化營養方法。該行業透過從醫院和診所到零售藥局和線上平台等多種分銷管道，服務於包括成人、青少年和兒童在內的各類人群。政府倡導健康生活方式的舉措、不斷成長的醫療保健支出，以及人們越來越接受體重管理是一種醫療必需品而非美容偏好，這些都進一步推動了市場的擴張，使其成為全球醫療保健生態系統的重要組成部分。

市場動態

全球減重和肥胖管理市場的主要驅動力是全球肥胖率的驚人成長。根據世界衛生組織 (WHO) 的報告，自 1975 年以來，肥胖人數增加了兩倍，這使得所有年齡層的人對有效的體重管理解決方案的需求都很大。人們對肥胖相關健康併發症（例如 2 型糖尿病、心血管疾病、睡眠呼吸中止症和某些癌症）的認知不斷提高，迫使人們尋求專業的體重管理干預措施，從而擴大了市場的消費群。微創手術的技術創新、先進藥物製劑的開發以及包括行動應用程式和穿戴式裝置在內的數位健康技術的整合，顯著提高了治療效果和患者依從性，推動了市場成長。然而，該市場也面臨重大限制因素，包括與外科手術相關的高成本和昂貴的體重管理計劃，這限制了低收入群體獲得這些服務的機會，並阻礙了其廣泛應用。減重藥物和醫療設備的嚴格法律規範，加上某些干預措施可能產生的副作用和安全問題，為市場擴張帶來了額外的挑戰。在某些地區，圍繞肥胖和體重管理治療的文化污名也阻礙了市場滲透。儘管存在這些挑戰，但在可支配收入不斷成長、都市化和飲食習慣不斷變化、新客戶群不斷湧現的市場中，仍存在著巨大的機會。預防性醫療保健的日益流行、遠端醫療日益普及，以及根據個人基因圖譜和生活方式因素量身定做的個人化營養和健身計劃的開發，對於尋求利用不斷變化的消費趨勢和醫療保健服務模式的開發商來說，代表著巨大的成長潛力。

本次調查的主要特點

• 本報告對全球減重和肥胖管理市場進行了詳細分析，提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），以 2024 年為基準年。
• 它揭示了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數，對全球減重和肥胖管理市場的主要企業進行了概述。
• 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、最新策略、市場擴張和行銷策略做出明智的決策。
• 本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 相關人員可以透過全球減肥和肥胖管理市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章：調查目標和先決條件

• 調查目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、法規與趨勢分析

• 市場動態
• 驅動程式
• 抑制因素
• 機會
• 影響分析
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景
• 產業趨勢

4. 2020-2032 年全球減重及肥胖管理市場（依治療類型）

• 介紹
• 微創/非手術治療

5. 全球減重及肥胖管理市場（依給藥途徑分類），2020 年至 2032 年

• 介紹
• 口服
• 腸外
• 其他（經皮）

6. 2020-2032 年全球減重及肥胖管理市場（依性別）

• 介紹
• 男性
• 女士

7. 2020-2032 年全球減重及肥胖管理市場（依年齡層分類）

• 介紹
• 成人
• 老年人
• 孩子們

8. 全球減重和肥胖管理市場（按最終用戶分類），2020 年至 2032 年

• 介紹
• 醫院和診所
• 門診手術中心（ASC）
• 居家照護
• 減重中心或健身中心
• 其他

9. 2020-2032 年全球減重及肥胖管理市場（按地區）

• 介紹
• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 東南亞國協
  • 其他亞太地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 南非
  • 北非
  • 中部非洲

第10章 競爭格局

• Novo Nordisk
• GlaxoSmithKline
• AstraZeneca
• Pfizer
• Merck & Co.
• Sanofi
• Amgen
• Eli Lilly and Company
• Johnson & Johnson
• Herbalife Nutrition Ltd
• GNC Holdings
• Amway
• Nestle Health Science
• Iovate Health Sciences
• Weight Watchers（WW International）
• SlimFast（Glanbia Performance Nutrition）
• Life Extension
• NutraScience Labs
• Other Players

第 11 章分析師建議

• 機會
• 一致的機會地圖

第12章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Weight Loss And Obesity Management Market is estimated to be valued at USD 165.10 Bn in 2025 and is expected to reach USD 295.09 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

The global weight loss and obesity management market represents a rapidly expanding healthcare sector driven by escalating obesity rates, increasing health consciousness, and growing awareness of obesity-related comorbidities worldwide. This market encompasses a comprehensive range of products and services including dietary supplements, meal replacements, fitness equipment, weight management devices, pharmaceutical interventions, and surgical procedures designed to facilitate weight reduction and maintain healthy body weight.

The market's growth trajectory is significantly influenced by rising prevalence of lifestyle-related diseases such as diabetes, cardiovascular disorders, and metabolic syndrome, which have created urgent demand for effective weight management solutions. Additionally, the market benefits from technological advancements in non-invasive treatment options, digital health platforms, and personalized nutrition approaches that cater to diverse consumer preferences and medical requirements. The industry serves various demographics including adults, adolescents, and pediatric populations through multiple distribution channels ranging from hospitals and clinics to retail pharmacies and online platforms. Government initiatives promoting healthy lifestyles, increasing healthcare expenditure, and growing acceptance of weight management as a medical necessity rather than cosmetic preference further propel market expansion, making it a critical component of the global healthcare ecosystem.

Market Dynamics

The global weight loss and obesity management market is primarily driven by the alarming increase in obesity rates globally, with the World Health Organization reporting that obesity has tripled since 1975, creating substantial demand for effective weight management solutions across all age groups. Rising awareness about obesity-related health complications including type 2 diabetes, cardiovascular diseases, sleep apnea, and certain cancers is compelling individuals to seek professional weight management interventions, thereby expanding the market's consumer base. Technological innovations in minimally invasive surgical procedures, development of advanced pharmaceutical formulations, and integration of digital health technologies including mobile applications and wearable devices are significantly enhancing treatment efficacy and patient compliance, driving market growth. However, the market faces considerable restraints including high costs associated with surgical interventions and premium weight management programs, which limit accessibility for lower-income populations and create barriers to widespread adoption. Stringent regulatory frameworks governing weight loss medications and medical devices, coupled with potential side effects and safety concerns associated with certain interventions, pose additional challenges to market expansion. Cultural stigma surrounding obesity and weight management treatments in certain regions also impedes market penetration. Despite these challenges, the market presents substantial opportunities through emerging economies where rising disposable incomes, urbanization, and changing dietary patterns are creating new customer segments. The growing trend toward preventive healthcare, increasing acceptance of telemedicine, and development of personalized nutrition and fitness programs tailored to individual genetic profiles and lifestyle factors offer significant growth potential for market players seeking to capitalize on evolving consumer preferences and healthcare delivery models.

Key Features of the Study

• This report provides in-depth analysis of the global weight loss and obesity management market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global weight loss and obesity management market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novo Nordisk, GlaxoSmithKline, AstraZeneca, Pfizer, Merck & Co., Sanofi, Amgen, Eli Lilly and Company, Johnson & Johnson, Herbalife Nutrition Ltd, GNC Holdings, Amway, Nestle Health Science, Iovate Health Sciences, Weight Watchers (WW International), SlimFast (Glanbia Performance Nutrition), Life Extension, and NutraScience Labs.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global weight loss and obesity management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global weight loss and obesity management market

Market Segmentation

• Type of Treatment Insights (Revenue, USD Bn, 2020 - 2032)
  • Drugs
  • Prescription Drugs
  • Over-the-Counter (OTC) Drugs
  • Dietary Supplements
  • Nutraceuticals
  • Herbal or Botanical Supplements
  • Protein and Fiber Supplements
  • Vitamin or Mineral Formulations (Weight-Loss Focused)
  • Appetite suppressants
  • Others (Metabolism enhancers, etc.)
  • Surgery Therapies
  • Bariatric Surgeries
  • Sleeve Gastrectomy
  • Biliopancreatic Diversion (BPD)
  • Others (Duodenal Switch, etc.)
  • Minimally Invasive or Non-Surgical Procedures
  • Intragastric Balloon Systems
  • Others (Endoscopic Sleeve Gastroplasty, etc.)
• Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
  • Oral
  • Parenteral
  • Others (Transdermal)
• Gender Insights (Revenue, USD Bn, 2020 - 2032)
  • Male
  • Female
• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Adult
  • Geriatric
  • Pediatric
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Homecare Settings
  • Obesity Treatment Centers or Fitness Centers
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Novo Nordisk
  • GlaxoSmithKline
  • AstraZeneca
  • Pfizer
  • Merck & Co.
  • Sanofi
  • Amgen
  • Eli Lilly and Company
  • Johnson & Johnson
  • Herbalife Nutrition Ltd
  • GNC Holdings
  • Amway
  • Nestle Health Science
  • Iovate Health Sciences
  • Weight Watchers (WW International)
  • SlimFast (Glanbia Performance Nutrition)
  • Life Extension
  • NutraScience Labs
  • Other Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Weight Loss and Obesity Management Market, By Type of Treatment
  • Global Weight Loss and Obesity Management Market, By Route of Administration
  • Global Weight Loss and Obesity Management Market, By Gender
  • Global Weight Loss and Obesity Management Market, By Age Group
  • Global Weight Loss and Obesity Management Market, By End User
  • Global Weight Loss and Obesity Management Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Weight Loss and Obesity Management Market, By Type of Treatment, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
    • Drugs
      • Prescription Drugs
      • Over-the-Counter (OTC) Drugs
    • Dietary Supplements
      • Nutraceuticals
      • Herbal or Botanical Supplements
      • Protein and Fiber Supplements
      • Vitamin or Mineral Formulations (Weight-Loss Focused)
      • Appetite suppressants
      • Others (Metabolism enhancers, etc.)
    • Surgery Therapies
      • Bariatric Surgeries
    • Sleeve Gastrectomy
    • Biliopancreatic Diversion (BPD)
    • Others (Duodenal Switch, etc.)
• Minimally Invasive or Non-Surgical Procedures
  • Intragastric Balloon Systems
  • Others (Endoscopic Sleeve Gastroplasty, etc.)

5. Global Weight Loss and Obesity Management Market, By Route of Administration, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Parenteral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Transdermal)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Weight Loss and Obesity Management Market, By Gender, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Male
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Female
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Weight Loss and Obesity Management Market, By Age Group, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Weight Loss and Obesity Management Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers (ASCs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Homecare Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Obesity Treatment Centers or Fitness Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Weight Loss and Obesity Management Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Novo Nordisk
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck & Co.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amgen
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Herbalife Nutrition Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GNC Holdings
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Amway
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nestle Health Science
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Iovate Health Sciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Weight Watchers (WW International)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SlimFast (Glanbia Performance Nutrition)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Life Extension
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• NutraScience Labs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Other Players
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us